Emerging Agents in the Pipeline for Merkel Cell Carcinoma
3 Vues
• 07/17/23
0
0
Intégrer
administrator
Les abonnés
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires